[go: up one dir, main page]

MX2023010368A - Composiciones antiparasitarias de uncion dorsal. - Google Patents

Composiciones antiparasitarias de uncion dorsal.

Info

Publication number
MX2023010368A
MX2023010368A MX2023010368A MX2023010368A MX2023010368A MX 2023010368 A MX2023010368 A MX 2023010368A MX 2023010368 A MX2023010368 A MX 2023010368A MX 2023010368 A MX2023010368 A MX 2023010368A MX 2023010368 A MX2023010368 A MX 2023010368A
Authority
MX
Mexico
Prior art keywords
pour
antiparasitic
compositions
disclosed
menthol
Prior art date
Application number
MX2023010368A
Other languages
English (en)
Inventor
Keith Freehauf
John Gerard Sheehan
Annie Flochlay-Sigognault
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=64949294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2023010368(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2023010368A publication Critical patent/MX2023010368A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/70—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Se describe una composición veterinaria líquida de unción dorsal o puntual que comprende al menos un compuesto de isoxazolina de fórmula (I) y un vehículo farmacéuticamente aceptable que comprende al menos un potenciador de la penetración dérmica 5 que comprende mentol y un sistema disolvente que comprende un disolvente de pirrolidona. Asimismo, se describen métodos para usar y administrar tal preparación en la prevención y control de infestaciones de parásitos en animales de ganado. (ver Fórmula).
MX2023010368A 2017-12-21 2020-07-13 Composiciones antiparasitarias de uncion dorsal. MX2023010368A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762608760P 2017-12-21 2017-12-21

Publications (1)

Publication Number Publication Date
MX2023010368A true MX2023010368A (es) 2023-09-12

Family

ID=64949294

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020006512A MX2020006512A (es) 2017-12-21 2018-12-21 Composiciones antiparasitarias de uncion dorsal.
MX2023010368A MX2023010368A (es) 2017-12-21 2020-07-13 Composiciones antiparasitarias de uncion dorsal.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2020006512A MX2020006512A (es) 2017-12-21 2018-12-21 Composiciones antiparasitarias de uncion dorsal.

Country Status (9)

Country Link
US (1) US12390450B2 (es)
EP (2) EP3727375B1 (es)
JP (2) JP7394059B2 (es)
AR (1) AR113997A1 (es)
AU (2) AU2018386568B2 (es)
CA (1) CA3085896A1 (es)
ES (1) ES3018480T3 (es)
MX (2) MX2020006512A (es)
WO (1) WO2019122324A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021122515A1 (en) * 2019-12-16 2021-06-24 Intervet International B.V. Parasite control in ruminants
EP4075981A1 (en) * 2019-12-16 2022-10-26 Intervet International B.V. Composition for lice control
AU2021311722A1 (en) 2020-07-24 2023-02-02 Elanco Us Inc. Process for making an isoxazoline compound and intermediate thereof
EP4430947A1 (en) * 2023-03-17 2024-09-18 Przedsiebiorstwo Wielobranzowe "Vet-Agro" Sp. Z O.O. Therapeutic use of isoxazoline compounds, composition of isoxazoline compounds and kit for therapeutic use
WO2025191150A2 (en) * 2024-03-15 2025-09-18 Krka, D.D., Novo Mesto Stable isoxazoline formulation for topical application to the skin
CN120053434B (zh) * 2025-02-28 2025-12-23 湖南尚成生物科技有限公司 一种弗雷拉纳滴剂及其制备方法
CN120531675A (zh) * 2025-06-11 2025-08-26 湖南尚成生物科技有限公司 一种氟雷拉纳莫昔克丁滴剂及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1731512T1 (sl) 2004-03-05 2015-01-30 Nissan Chemical Industries, Ltd. Z izoksazolinom substituirana benzamidna spojina in sredstvo za uravnavanje škodljivih organizmov
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
BRPI0810196A2 (pt) 2007-04-10 2011-12-06 Bayer Cropscience Ag inseticidas de derivados de aril isoxazolina
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
EP2957284B1 (en) 2007-06-27 2018-01-17 E. I. du Pont de Nemours and Company Animal pest control method
TWI556741B (zh) 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
CN101909450B (zh) 2007-11-26 2014-04-23 梅里亚有限公司 用于抗击寄生物的浇泼配制剂的溶剂系统
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
EP2293777B1 (en) 2008-06-24 2015-02-25 Intervet International B.V. Pharmaceutical transdermal compositions and method for treating inflammation in cattle
US8377942B2 (en) 2008-12-18 2013-02-19 Novartis Ag Isoxazolines derivatives and their use as pesticide
BRPI0923009B1 (pt) 2008-12-19 2018-07-17 Elanco Tiergesundheit Ag compostos de isoxazolina, composição para o controle de parasitas e uso de compostos de isoxazolina para o preparo de composição para o controle de parasitas
MX336189B (es) 2009-12-17 2016-01-11 Merial Ltd Compuesto de dihidroazol antiparasiticos y composiciones qe¡ue comprenden los mismos.
WO2011124998A1 (en) 2010-04-08 2011-10-13 Pfizer Inc. Substituted 3,5- di phenyl - isoxazoline derivatives as insecticides and acaricides
AU2011351579B2 (en) 2010-12-27 2016-04-21 Intervet International B.V. Topical localized isoxazoline formulation comprising glycofurol
ES2908094T5 (en) * 2010-12-27 2025-08-12 Intervet Int Bv Topical localized isoxazoline formulation
WO2012155352A1 (en) 2011-05-19 2012-11-22 Eli Lilly And Company Dihydroisoxazole compounds, parasiticidal uses and formulations thereof
CN106474120B (zh) 2011-09-12 2020-07-28 勃林格殷格翰动物保健美国公司 包含异噁唑啉活性剂的杀寄生物组合物，其方法和用途
CN108685894B (zh) 2012-04-04 2022-04-26 英特维特国际股份有限公司 软咀嚼药用产品
SI2892347T1 (sl) 2012-09-07 2019-10-30 Zoetis Services Llc Paraziticidne kombinacije spirocikličnega isoksazolina
CA2902282C (en) * 2013-02-27 2023-03-14 Laurie Robert BATT Transdermal formulations
AR096346A1 (es) 2013-05-20 2015-12-23 Zoetis Llc Composiciones antiparasitarias de espiro-isoxazolina de acción prolongada
FI3052080T3 (fi) 2013-09-30 2025-08-22 Zoetis Services Llc Pitkävaikutteisia spiro-isoksatsoliiniformulaatioita
US9371293B2 (en) 2013-10-25 2016-06-21 Sumitomo Chemical Company, Limited Isoxazoline compound composition
EA030935B1 (ru) 2013-11-01 2018-10-31 Мериал, Инк. Антипаразитарные и пестицидные изоксазолиновые соединения

Also Published As

Publication number Publication date
WO2019122324A1 (en) 2019-06-27
JP7394059B2 (ja) 2023-12-07
EP4559482A3 (en) 2025-07-30
JP2021507891A (ja) 2021-02-25
ES3018480T3 (es) 2025-05-16
MX2020006512A (es) 2020-09-07
AR113997A1 (es) 2020-07-08
JP7627312B2 (ja) 2025-02-05
BR112020012465A2 (pt) 2020-11-24
US20200390748A1 (en) 2020-12-17
AU2018386568A1 (en) 2020-06-11
EP4559482A2 (en) 2025-05-28
RU2020123896A (ru) 2022-01-21
AU2018386568B2 (en) 2024-02-22
CA3085896A1 (en) 2019-06-27
AU2024203397A1 (en) 2024-06-06
US12390450B2 (en) 2025-08-19
EP3727375B1 (en) 2025-03-19
EP3727375A1 (en) 2020-10-28
JP2023154054A (ja) 2023-10-18

Similar Documents

Publication Publication Date Title
MX2023010368A (es) Composiciones antiparasitarias de uncion dorsal.
MY167560A (en) Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
NZ763636A (en) Prolonged ectoparasite-controlling agent for animal
IL273592A (en) A multispecific antigen-binding molecule that has the function-changing activity of a cofactor for blood coagulation factor viii (fviii), and a pharmaceutical formulation containing the molecule as an active ingredient
PH12019501685A1 (en) Quinazone compound
MX2017012848A (es) Formulaciones inyectables de liberacion extendida que comprenden un agente activo de isoxazolina, metodos y usos de las mismas.
NZ628874A (en) Parasiticidal compositions comprising multiple active agents, methods and uses thereof
IN2014CN02128A (es)
PH12019502150A1 (en) Compounds and methods for the treatment of parasitic diseases
EA202090500A1 (ru) Кристаллические формы иммуномодуляторов
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
MX2019007583A (es) Vacuna de eimeria con una eficacia mejorada.
ZA202007060B (en) Solid formulation of insecticidal mixtures
MX2020014262A (es) Composicion farmaceutica que comprende un agente basico poco soluble.
MX2015001137A (es) Formulaciones orales de dosis unica y metodos para el tratamiento de gatos con el ectoparasiticida espinosad.
MX2020000144A (es) Composicion farmaceutica para administracion nasal.
MY191848A (en) Respiratory infection treating agent
NO20081754L (no) Anthelmintiske formuleringer
EA202091455A1 (ru) Стабилизированный фармацевтический состав, содержащий эверолимус
MX2020006259A (es) Composiciones para la proteccion de cultivos agrarios y uso de las mismas.
NZ594610A (en) Injectable Anthelmintic Formulations cotaining levamisole and one or more macrocyclic lactones for controlling internal parasites in ruminants
NZ755538A (en) Antiparasitic isoxazoline compounds, long-acting injectable formulations comprising them, methods and uses thereof
NZ755538B2 (en) Antiparasitic isoxazoline compounds, long-acting injectable formulations comprising them, methods and uses thereof
GB2571235A (en) Antimicrobial formulations for the improved treatment of veterinary hoof infections
UA94511U (uk) Фармацевтична композиція на основі продуктів бджільництва для місцевого лікування виразки шлунка та дванадцятипалої кишки